Abstract: CHF's submission to the RACGP's Vision for a Sustainable Health System Discussion Paper.Read more
About Policy Submissions
We regularly make submissions to national level inquiries. If you are after a submission from earlier than listed here, please contact us.
The Consumers Health Forum of Australia (CHF) is pleased to provide a submission to the Issues Paper for the Post-Market Review of the Life-Saving Drugs Programme (the Issues Paper). Before going into the content of our views, we want to express our deep concerns with the limitations the Review...Read more
This submission into the Availability of new, innovative and specialist cancer drugs in Australia draws on the experiences of our members and consumer representatives in assessing the availability and effectiveness of medicines in Australia, and in particular the operation of the Pharmaceutical...Read more
The definitive goal of this review of the regulatory framework should be the safety and quality of complementary medicines in Australia. Any new framework must carefully balance the risk to consumer safety and consumer choice concerns.Read more
The Consumers Health Forum of Australia (CHF) is the national peak body representing the
interests of Australian healthcare consumers. CHF works to achieve safe, quality, timely healthcare
for all Australians, supported by accessible health information and systems. CHF welcomes the...Read more
CHF considers this review to be of critical importance to every Australian health consumer.
Consumers consistently raise with us their concerns about the safety and quality of medicines,
giving details of personal experiences of when the safety regime has failed them. With this in...Read more
CHF supports that any health care service be based on the principles of consumer-centred healthcare and that it considers the patient, their carer and family. The key principles of consumercentred healthcare are inclusive of safety and quality issues, cost and sustainability.Read more
CHF has strongly opposed policies that increase consumer out-of-pocket costs through the imposition of new or increased co-payments. We have raised these concerns consistently through previous submissions to Senate Committee inquiries. CHF’s commissioned research on out-ofpocket costs highlights...Read more
CHF welcomes the review into the Personally Controlled Electronic Health Records (PCEHR) System. CHF has undertaken extensive work on eHealth, particularly in relation to the PCEHR. Our submission draws on consultations with our membership, which includes organisations advocating for disease specific groups and networks, state and territory peak consumer organisations and individual consumers. CHF’s submission also draws on consultations undertaken through our Facilitating Consumer Input on the PCEHR Project, as well as previous submissions to consultations relating to the PCEHR. CHF also conducted an eHealth consultation in Feb 2012 as part of the Community Quality Use of Medicines and Medical Tests (CQUM/T) Project.Read more
CHF considers that the current Inquiry provides a valuable opportunity to review the Government’s response to the numerous recent regulatory reviews outlined in TGA Reforms: A blueprint for the TGA’s future, which was released in December 2011. However, we note that the TGA is still in the...Read more